entertainment -WSS

entertainment

author：fashion 2025-09-06 03:50:52 - browse：537

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Medical mystery: When a cough is not just a cough

hotspot

WSS

KalVista pill reduced swelling 'attacks' caused by genetic disease

My superpower is killing ticks

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Nearly two

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

'Ancient DNA,' 23andMe reveal African American ancestries

knowledge

entertainment

focus

New air purifier tech could be key to improving indoor air quality

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

Tori Bowie and the unacceptable rates of Black maternal death

Senators start work on Medicare physician payment reform

Moonlake's readout produced a cash windfall. Risks remain

'Ancient DNA,' 23andMe reveal African American ancestries

Malaria cases in Florida and Texas: Here’s what you need to know

PhRMA lawsuit over Medicare drug price negotiation tossed

In age of alternative facts, a scholarly course on calling out crap

'Revelatory' study finds a smoking impact that remains after quitting

focus

Dramatically reducing cancer deaths requires the PASTEUR Act

The Readout: Gilead, Bernie Sanders, and other pharma news

Influencer to be charged after chaos erupts in New York City's Union Square

My superpower is killing ticks

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

'Ancient DNA,' 23andMe reveal African American ancestries

entertainment

hotspot

hotspot

focus